Craig England, the founding partner of England & Company, is an investment banker with over 30 years of experience in M&A advisory, financial restructuring services, and private finance.
Prior to forming England & Company, Mr. England was a Principal in Legg Mason’s Investment Banking Group where he concentrated on software and financial services companies. Prior to Legg Mason, he was a Vice President with Alex. Brown & Sons in New York and Baltimore where he led the firm’s Asset Securitization Group. Additionally, Mr. England served as a Vice President and private placement specialist at New York City-based Hunter, Keith, Marshall & Co., and Corporate Finance Director for ICON Capital Corp. He began his career as a corporate lender in the financial institutions groups of the Irving Trust Company (now the Bank of New York) and the Canadian Imperial Bank of Commerce.
Mr. England earned his BA from the Johns Hopkins University, completed studies in International Economics at the Universite Libre de Bruxelles and received his MBA in Finance from the Stern School of Business at New York University.
Andy Cowherd has over 25 years of investment banking and private equity investing experience focused on the healthcare sector. In these roles, he has completed a wide range of M&A and strategic advisory assignments, as well as numerous private and public financings, as both an advisor and principal.
Prior to joining England & Company in 2015, Mr. Cowherd was a Managing Director of Healthcare Investment Banking at Mesirow Financial. He also served as a Managing Director at Peter J. Solomon Company, Salomon Brothers, and BT Securities / Bankers Trust Co. In addition, Mr. Cowherd was a founding member and General Partner of Atlantic Medical Capital, LP, a private equity firm focused on the healthcare industry.
Mr. Cowherd earned his AB from Princeton University and his MBA from the Stanford University Graduate School of Business.
Patrick O’Shea has over 15 years of investment banking and venture capital experience. Over the course of his career, he has participated in more than $11.5 billion of financings for companies in the energy, financial services, and telecommunications and technology sectors.
Prior to joining England & Company, Mr. O’Shea was a senior member of Cora Capital Advisors’ Corporate Finance team, where he focused on advising energy technology companies. Previously, Mr. O’Shea was a Vice President in JPMorgan’s Investment Banking division working in New York and Tokyo. Before joining JPMorgan’s Investment Banking division, Mr. O’Shea worked for LabMorgan, JPMorgan’s proprietary venture capital division. Mr. O’Shea began his career as a member of Merrill Lynch’s Investment Banking unit where he advised technology and telecommunications companies.
Mr. O’Shea earned his BSFS from Georgetown University’s School of Foreign Service, where he majored in International Economics with a background in Finance and Trade.
Paul Teitelbaum has over 25 years of healthcare investment banking, corporate development, and management experience, with a particular focus on medical technology and life sciences. He has completed numerous M&A, financing, and strategic partnership transactions for private and public companies.
Prior to joining England & Company in 2015, Mr. Teitelbaum was Managing Director of the Healthcare Investment Banking Group at Mesirow Financial. He also served as a Managing Director of Healthcare Investment Banking at Landmark Ventures, and as a healthcare investment banker at Robertson Stephens and Burnham Securities. Previously, Mr. Teitelbaum held corporate development and disease management roles at Schering-Plough (now Merck & Co., Inc.) and Wyeth-Lederle (now Pfizer, Inc.).
Mr. Teitelbaum received his BA in Biology summa cum laude from the University of Pennsylvania and his MBA in Finance from the Wharton School of the University of Pennsylvania.
Scott Cousino has over 30 years of investment banking experience primarily focused on the healthcare sector where he has completed a wide range of M&A, strategic advisory, and capital markets transactions.
Prior to joining England & Company in 2013, Mr. Cousino was a Managing Director at Stifel Nicolaus Weisel, where he had served as Head of its Healthcare Investment Banking Group. He also served as a Managing Director and Head of Healthcare Investment Banking at Legg Mason prior to its acquisition by Stifel in 2005. In addition, Mr. Cousino served as Chairman of the Fairness Opinion Committee at Stifel and Legg Mason for over ten years.
Mr. Cousino earned his BBA and MBA in Finance from the College of William and Mary. He has been active on numerous non-profit boards and currently serves on the Finance Committee of the Y of Central Maryland.
